Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Corey Langer, MD
Videos
How to Handle Elderly Patients and Those With Performance Status 2 NSCLC
09/28/2023

Featuring Corey Langer, MD

Featuring Corey Langer, MD
At the Great Debates & Updates in Lung Cancer meeting Corey Langer, MD, discussed the therapeutic landscape for underserved patients with non-small cell lung cancer — elderly patients, and patients with ECOG performance status 2.
At the Great Debates & Updates in Lung Cancer meeting Corey Langer, MD, discussed the therapeutic landscape for underserved patients with non-small cell lung cancer — elderly patients, and patients with ECOG performance status 2.
At the Great Debates & Updates...
09/28/2023
Oncology
Patrick Forde, MD
Videos
The Case for Adjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
09/26/2023

Featuring Patrick Forde, MD

Featuring Patrick Forde, MD
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Patrick Forde, MD, debated in favor of adjuvant immunotherapy in resectable non-small cell lung cancer.
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Patrick Forde, MD, debated in favor of adjuvant immunotherapy in resectable non-small cell lung cancer.
At the Great Debates & Updates...
09/26/2023
Oncology
Hossein Borghaei, DO, MS
Videos
Novel Checkpoint Inhibitor Combinations for Lung Cancer
09/26/2023

Featuring Hossein Borghaei, DO, MS

Featuring Hossein Borghaei, DO, MS ...
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Hossein Borghaei, DO, MS, discussed the development of novel combinations of checkpoint inhibitors to better treat patients with refractory lung cancers.
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Hossein Borghaei, DO, MS, discussed the development of novel combinations of checkpoint inhibitors to better treat patients with refractory lung cancers.
At the Great Debates & Updates...
09/26/2023
Oncology
Charles B. Simone II, MD
Videos
The Case for Prophylactic Cranial Irradiation in Small-Cell Lung Cancer
09/26/2023

Featuring Charles B. Simone, MD

Featuring Charles B. Simone, MD ...
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Charles Simone, MD, debated in favor of prophylactic cranial irradiation when considering treatment options for patients with small-cell lung cancer.
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Charles Simone, MD, debated in favor of prophylactic cranial irradiation when considering treatment options for patients with small-cell lung cancer.
At the Great Debates & Updates...
09/26/2023
Oncology
Lyudmila Bazhenova, MD
Videos
Management of BRAF-Mutated Non-Small Cell Lung Cancer
09/26/2023

Featuring Lyudmila Bazhenova, MD

Featuring Lyudmila Bazhenova, MD ...
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Lyudmila Bazhenova, MD, discussed developments and advances in the management of BRAF-mutated NSCLC.
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Lyudmila Bazhenova, MD, discussed developments and advances in the management of BRAF-mutated NSCLC.
At the Great Debates & Updates...
09/26/2023
Oncology
Hossein Borghaei, DO, MS
Videos
The Case for Using Immunotherapy for Patients With Low or Negative PD-L1
09/26/2023

Featuring Hossein Borghaei, DO, MS

Featuring Hossein Borghaei, DO, MS ...
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Hossein Borghaei, DO, MS, debated in favor of using immunotherapy among patients with non-small lung cancer and PD-L1 expressions of
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Hossein Borghaei, DO, MS, debated in favor of using immunotherapy among patients with non-small lung cancer and PD-L1 expressions of
At the Great Debates & Updates...
09/26/2023
Oncology
Natasha Leighl, MD
Videos
Targeted Therapies for MET-Dependent Lung Cancers
09/26/2023

Featuring Natasha Leighl, MD

Featuring Natasha Leighl, MD
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Natasha Leighl, MD, discussed advances in targeted therapies for patients with MET-dependent lung cancers.
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Natasha Leighl, MD, discussed advances in targeted therapies for patients with MET-dependent lung cancers.
At the Great Debates & Updates...
09/26/2023
Oncology
Natasha Leighl, MD
Videos
Primacy of Front-Line Checkpoint Inhibitors in Non-Small Cell Lung Cancer
09/26/2023

Featuring Natasha Leighl, MD, FRCPC, FASCO

Featuring Natasha Leighl, MD, FRCPC, ...
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Natasha Leighl, MD, FRCPC, FASCO, discussed the primacy of front-line checkpoint inhibitors in non-small cell lung cancer.
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Natasha Leighl, MD, FRCPC, FASCO, discussed the primacy of front-line checkpoint inhibitors in non-small cell lung cancer.
At the Great Debates & Updates...
09/26/2023
Oncology
Ignacio Wistbua, MD
Videos
Challenges and Opportunities of Biomarker Diagnostics in Lung Cancer
09/23/2023

Featuring Ignacio Wistuba, MD

Featuring Ignacio Wistuba, MD
At Great Debates & Updates in Lung Cancer, Ignacio Wistuba, MD, discussed the challenges and opportunities associated with biomarker diagnostics in lung cancer.
At Great Debates & Updates in Lung Cancer, Ignacio Wistuba, MD, discussed the challenges and opportunities associated with biomarker diagnostics in lung cancer.
At Great Debates & Updates in...
09/23/2023
Oncology
Deborah Doroshow, MD, PhD
Videos
RET, NTRK, NRG1, and ROS1 Fusions as Targets in Lung Cancer
09/23/2023

Featuring Deborah Doroshow, MD, PhD 

Featuring Deborah Doroshow, MD, PhD  ...
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Deborah Doroshow, MD, PhD, discussed the importance of screening patients with lung cancer for RET, ROS1, NTRK, and NRG1 fusions.
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Deborah Doroshow, MD, PhD, discussed the importance of screening patients with lung cancer for RET, ROS1, NTRK, and NRG1 fusions.
At the Great Debates & Updates...
09/23/2023
Oncology

Advertisement

About

Formerly known as Perspectives in Thoracic Oncology, the lung cancer meeting you know and love is getting a makeover. With an updated name to reflect a more pronounced focus on targeted therapies, biomarker testing and precision medicine, year 25 of this educational gathering is getting practical. Personalized Therapies in Thoracic Oncology will go beyond chemotherapy and focus on the best way to treat your patients when traditional methods aren't cutting it. 

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use